Ji Qiu, Arizona State University (IMAGE) Arizona State University Caption A new study, led by Biodesign scientists Josh LaBaer and Ji Qiu (pictured), along with gastroenterologists Shabana Pasha and Jonathan Leighton from Mayo Clinic Arizona, successfully identified several molecules, called biomarkers, that were unique indicators found only in patients with Crohn's disease. Credit Biodesign Institute, ASU Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.